Real-world Data on patients being treated with teclistamab | Artur Jurczyszyn, MD

My name is Artur Jurczyszyn. I am from Jagiellonian University from Krakow. I will present here in Orlando a poster. It will be 87 patients on Teclistamab therapy, real world data. This is a Polish data from 16 centers, from Krakow, from Toruń, from Gdańsk, Lublin, etc. This is real world data and we prove that this drug is very safe for patients. When we compared to Majestic One trial, this is a registration trial, we saw a little less infection and a little less neutropenia in our patients. So I think for our patients it is very safe and fixed duration therapy is also important. And I am happy that in third or fifth line therapy I can offer such drug and patients can help in such ways our patients. Thank you. Your gift will go three times as far when we reach $500,000 by the end of the year. Every contribution, big or small, makes a difference and we are deeply grateful for your support.